CClinicalTrials.gg
RecruitingNCT06370689Updated Mar 28, 2025

Comparison of Three Pre-oxygenation Strategies

An interventional study of Preoxygenation in Emergencies and Anesthesia, sponsored by Institute of Mountain Emergency Medicine. Recruiting at 1 site in Italy. Open to participants aged 6 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-28.

Sponsored by Institute of Mountain Emergency Medicine · Not applicable, Interventional, and Other

From the registry’s dates

  • Started May 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
6 Years and older
Sex
All
01

Study summary

Study objective: Comparing the efficacy of three different preoxygenation strategies, i.e. non-rebreather face mask (NRM), bag-valve-mask (BVM) with and BVM without additional positive end-expiratory pressure (PEEP) in three subgroups of spontaneously breathing volunteers.

Study endpoints

Primary Endpoint:

Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions.

Secondary endpoints:

  • Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions.
  • Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)
  • Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5
  • Time to reaching an Oxygen Reserve Index (ORi) =1
  • Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.

Number of participants 15 participants per subgroup, i.e. 45 participants in total.

Inclusion criteria

  • Normal-weight adults (body mass index, BMI 18.5-24.9 kg/m2) with an "American Society of Anesthesiologists Physical Status Classification System (ASA) " score of I or II
  • Adults with a BMI 25-39.9 kg/m2 with and ASA score \<3
  • Healthy (ASA I) children aged 6-12 years Exclusion criteria ASA 3, Age \< 6 and age 12-18, pregnant women, missing informed consent, signs and symptoms of an acute respiratory illness on the study day.

After informed consent and a medical check-up, baseline measurements will be done for 10 minutes (peripheral oxygen saturation SpO2, ORI, regional ventilation). Then the participants will undergo 3 different preoxygenation sessions with the 3 interfaces (i.e. non-rebreather facemask with reservoir and a bag-valve-mask with and without PEEP) in a randomized order and a 20 min washout between the sessions. Each preoxygenation session is conducted in a supine position and will be proceeded until the measured FeO2 (end expiratory O2 fraction) reaches 90% or up to a maximum time of 3 min. Afterwards 10 min of SpO2, ORI and regional ventilation measurements will follow.

02

Conditions studied

  • Emergencies
  • Anesthesia

Browse trials for

03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's planned enrollment of 45 is below the median of 145 across 931 interventional studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Institute of Mountain Emergency Medicine is the lead sponsor of 20 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Normal-weight adults (BMI 18.5-24.9 kg/m2) with an "American Society of Anesthesiologists Physical Status Classification System (ASA) " score of I or II
  • Adults with a BMI 25-39.9 kg/m2 with and ASA score \<3
  • Healthy (ASA I) children aged 6-12 years

Exclusion criteria

Exclusion Criteria:

  • ASA 3
  • Age \< 6 and age 12-18
  • pregnant women
  • missing informed consent
  • signs and symptoms of an acute respiratory illness on the study day
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
45 participants (estimated)

Study arms

  • Active comparator
    NRM - Non-rebreather mask in children 6-12 yrs

    Non-rebreather mask in children 6-12 yrs

    Other: Preoxygenation

  • Active comparator
    BVM with PEEP in children 6-12 yrs

    Bag valve mask with positive end-expiratory pressure (PEEP) in children 6-12 yrs

    Other: Preoxygenation

  • Active comparator
    BVM without PEEP in children 6-12 yrs

    Bag valve mask without positive end-expiratory pressure (PEEP) in children 6-12 yrs

    Other: Preoxygenation

  • Active comparator
    NRM - Non-rebreather mask in normal weight adults

    Non-rebreather mask in normal weight adults

    Other: Preoxygenation

  • Active comparator
    BVM with PEEP in normal weight adults

    Bag valve mask with positive end-expiratory pressure (PEEP) in normal weight adults

    Other: Preoxygenation

  • Active comparator
    BVM without PEEP in normal weight adults

    Bag valve mask without positive end-expiratory pressure (PEEP) in normal weight adults

    Other: Preoxygenation

  • Active comparator
    NRM - Non-rebreather mask in overweight/obese adults

    Non-rebreather mask in overweight/obese adults

    Other: Preoxygenation

  • Active comparator
    BVM with PEEP in overweight/obese adults

    Bag valve mask with positive end-expiratory pressure (PEEP) in overweight/obese adults

    Other: Preoxygenation

  • Active comparator
    BVM without PEEP in overweight/obese adults

    Bag valve mask without positive end-expiratory pressure (PEEP) in overweight/obese adults

    Other: Preoxygenation

Interventions

  • OtherPreoxygenation

    Preoxygenation of volunteers over 3 minutes

06

What researchers measure

Primary outcomes

  1. Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions.

    Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions between the three arms.

    Time frame: After 3 minutes of preoxygenation

Secondary outcomes

  1. Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions.

    Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions. ORi ranges from 0.0 to 1.0 and reflects the partial pressure of oxygen in arterial blood (PaO2 80-200).

    Time frame: After 3 minutes of preoxygenation

  2. Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)

    Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)

    Time frame: After 1.5 and 3 minutes of preoxygenation

  3. Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5

    Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5

    Time frame: Variable, timepoint during the 3 min preoxygenation session

  4. Time to reaching an Oxygen Reserve Index (ORi) =1

    Time to reaching an Oxygen Reserve Index (ORi) =1

    Time frame: Variable, timepoint during the 3 min preoxygenation session

  5. Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.

    Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.

    Time frame: Washout phase after the 3 min preoxygenation sessions.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06370689
Lead sponsor
Institute of Mountain Emergency Medicine
Responsible party
Sponsor
First posted
Apr 17, 2024
Start date
May 23, 2024
Primary completion
Dec 31, 2024
Completion
Jul 30, 2025 (estimated)
Last update
Mar 28, 2025

Study contacts

Simon Rauch, MD, PhD
Contact
simon.rauch@eurac.edu
00393404967398
Giulia Roveri, MD
Contact
giulia.roveri@eurac.edu
Simon Rauch, MD, PhD
principal investigator · Institute of Mountain Emergency Medicine, Eurac Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion